mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
Ifat Rubin-Bejerano, Isabelle Sansal-Castellano, Mark Carlson, Gabriel Reznik, James Siedlecki, John Kane, Zuzana Dostalova, Hua Miao
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P262; DOI: 10.1186/2051-1426-2-S3-P262
